Jail-Based program aims to cut HIV risk after release
NCT ID NCT06919419
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a program in the Dallas County Jail that identifies people at high risk for HIV and offers them testing and education about PrEP, a daily pill that prevents HIV. A patient navigator helps interested individuals connect with PrEP providers after they are released. The study will measure how many people actually attend a PrEP appointment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- PrEP patient navigation and education program
- What this could lead to
- If successful, this could show that offering HIV prevention services in jail helps people start PrEP after release, reducing new HIV infections.
- What could go wrong
- This is an early implementation study, not a drug trial. It may not prove that the program actually prevents HIV, only that people attend PrEP appointments. Results may not apply to other jails.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dallas County Jail
RECRUITINGDallas, Texas, 75207, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?